Liebo, Greta2009-05-042009-05-042009-05-04https://hdl.handle.net/11299/49541The information provided in this handout does not necessarily reflect the views of the University of Minnesota Medical School physicians and faculty. These materials are provided for informational purposes only and are in no way intended to take the place of the advice and recommendations of your personal health care provider. You use the information provided in these handouts at your own risk.In patients with impaired fasting glucose and impaired glucose tolerance, lifestyle intervention can delay or prevent the development of diabetes by 58% over 3 years in all populations. Metformin can also delay or prevent the development of diabetes by 31% over 3 years. However, the effectiveness of metformin is limited to patients less than 60 years in age, with a BMI > 30 kg/m2.en-USPre-diabetesImpaired Fasting GlucoseImpaired Glucose ToleranceMetforminOther